Patients were treated for 12 weeks with the 3 - drug combination regimen, with 24 weeks of follow - up after completion of treatment. (sciencedaily.com)
Exploiting the same pre-clinical model used for their studies, the researchers are testing the efficacy of this kind of drug candidates against cancer stem cells, and the possibility of identifying combination regimens with standard chemotherapies with minimized toxic effects, with the perspective of their possible application for the treatment of human breast cancer. (sciencedaily.com)
In the current combination regimen, patients received a median of 10 infusions of CT - 011. (cancernetwork.com)